Skip to main content
Log in

Evaluation the effect of cyclodextrin complexation on aqueous solubility of fluorometholone to achieve ophthalmic solution

  • Original Article
  • Published:
Journal of Inclusion Phenomena and Macrocyclic Chemistry Aims and scope Submit manuscript

Abstract

In this study, the effect of different CDs including α-CD, β-CD, γ-CD, hydroxypropyl β-CD (HP β-CD), sulphobutylether β-CD (SBE β-CD) and HP γ-CD on aqueous solubility of fluorometholone (Flu) was investigated. Also the phase solubility studies were performed in the presence of eye drop excipients such as benzalkonium chloride, hydroxypropyl methylcellulose (HPMC) and buffers. The aqueous solubility of Flu was increased by 8, 15, 5, 100, 65 and 135 folds in the presence of 20% w/v α-CD, β-CD, γ-CD, HP β-CD, HP γ-CD and SBE β-CD, respectively. Aqueous solubility of Flu was 0.43 ± 0.08 and 1.16 ± 0.04 mg/mL in systems containing 5% w/v HP γ-CD and SBE β-CD, respectively. The aqueous solubility of Flu in the presence of HP γ-CD was not influenced by buffer type while the phosphate buffer caused a reduction in the aqueous solubility in the presence of SBE-β-CD. Also, investigations on the solubility of Flu in water in the presence of 5% HP γ-CD and SBE-β-CD and the additives such as benzalkonium chloride and HPMC indicated that these components had no remarkable effect on the aqueous solubility of Flu. In conclusion, CD complexation is able to improve the aqueous solubility of Flu and it would be possible to prepare ophthalmic solution of Flu by this method.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Martin Del Valle, E.M.: Cyclodextrins and their uses: a review. Process Biochem. 39, 1033–1046 (2004). doi:10.1016/S0032-9592(03)00258-9

    Article  Google Scholar 

  2. Davis, M.E., Brewster, M.E.: Cyclodextrin-based pharmaceutics: past, present and future. Nat. Rev. Drug Discov. 3, 1023–1035 (2004). doi:10.1038/nrd1576

    Article  CAS  Google Scholar 

  3. Brewster, M.E., Loftsson, T.: Cyclodextrins as pharmaceutical solubilizers. Adv. Drug Deliv. Rev. 59, 645–666 (2007). doi:10.1016/j.addr.2007.05.012

    Article  CAS  Google Scholar 

  4. Loftsson, T., Brewster, M.E.: Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 85, 1017–1025 (1996). doi:10.1021/js950534b

    Article  CAS  Google Scholar 

  5. Singla, A.K., Garg, A., Aggarwal, D.: Paclitaxel and its formulations. Int. J. Pharm. 235, 179–192 (2002). doi:10.1016/S0378-5173(01)00986-3

    Article  CAS  Google Scholar 

  6. Spulber, M., Pinteala, M., Fifere, A., Moldoveanu, C., Mangalagiu, I., Harabagiu, V., Simionescu, B.C.: Water soluble complexes of methyl b-cyclodextrin and sulconazole nitrate. J. Incl. Phenom. Macrocycl. Chem. 62, 135–142 (2008). doi:10.1007/s10847-008-9448-y

    Article  CAS  Google Scholar 

  7. Ohta, K., Konno, S., Endo, Y.: Complexation of b-cyclodextrin with carborane derivatives in aqueous solution. Tetrahedron Lett. 49, 6525–6528 (2008). doi:10.1016/j.tetlet.2008.08.107

    Article  CAS  Google Scholar 

  8. Shaimaa, M., Badr-Eldin, S.M., Seham, A., Elkheshen, S.A., Mahmoud, M., Ghorab, M.M.: Inclusion complexes of tadalafil with natural and chemically modified b-cyclodextrins. I: Preparation and in vitro evaluation. Eur. J. Pharm. Biopharm. 70, 819–827 (2008). doi:10.1016/j.ejpb.2008.06.024

    Article  Google Scholar 

  9. Larsen, K.L., Aachmann, F.L., Wimmer, R., Stella, V.J., Kjolner, U.M.: Phase solubility and structure of the inclusion complexes of prednisolone and 6a-methyl prednisolone with various cyclodextrins. J. Pharm. Sci. 94, 507–515 (2005). doi:10.1002/jps.20192

    Article  CAS  Google Scholar 

  10. Malaekeh-Nikouei, B., Nassirli, H., Davies, N.: Enhancement of cyclosporine aqueous solubility using a- and hydroxypropyl b-cyclodextrin mixtures. J. Incl. Phenom. Macrocycl. Chem. 59, 245–250 (2007). doi:10.1007/s10847-007-9321-4

    Article  CAS  Google Scholar 

  11. Kristinsson, J.K., Fridriksddttir, H., Thorisdottir, S., Sigurdardot, A.M.: Dexamethasone-cyclodextrin-polymer co-complexes in aqueous eye drops. Invest. Ophthalmol. Vis. Sci. 37, 1199–1203 (1996)

    CAS  Google Scholar 

  12. Friedlaender, M.: Overview of ocular allergy treatment. Curr. Allergy Asthma Rep. 1, 375–379 (2001). doi:10.1007/s11882-001-0051-1

    Article  CAS  Google Scholar 

  13. Bielory, L., Friedlaender, M.H.: Allergic conjunctivitis. Immunol. Allergy Clin. North Am. 28, 43–58 (2008). doi:10.1016/j.iac.2007.12.005

    Article  Google Scholar 

  14. Loftsson, T., Stefansson, E.: Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye. Acta Ophthalmol. Scand. 80, 144–150 (2002). doi:10.1034/j.1600-0420.2002.800205.x

    Article  CAS  Google Scholar 

  15. Loftssona, T., Jarvinen, T.: Cyclodextrins in ophthalmic drug delivery. Adv. Drug Deliv. Rev. 36, 59–79 (1999). doi:10.1016/S0169-409X(98)00055-6

    Article  CAS  Google Scholar 

  16. Stefansson, E., Loftsson, T.: Cyclodextrins in eye drop formulations. J. Incl. Phenom. Macrocycl. Chem. 44, 23–27 (2002). doi:10.1023/A:1023015201493

    Article  CAS  Google Scholar 

  17. Usayapant, A., Karara, A.H., Narurkar, M.M.: Effect of 2-hydroxypropyl β-cyclodextrin on the ocular absorption of dexamethasone and dexamethasone acetate. Pharm. Res. 8, 1495–1499 (1991). doi:10.1023/A:1015838215268

    Article  CAS  Google Scholar 

  18. Aktaş, Y., Unlü, N., Orhan, M., Irkeç, M., Hincal, A.A.: Influence of hydroxypropyl beta-cyclodextrin on the corneal permeation of pilocarpine. Drug Dev. Ind. Pharm. 29, 223–230 (2003). doi:10.1081/DDC-120016730

    Article  Google Scholar 

  19. Fridriksdottir, H., Loftsson, T., Stefansson, E.: Formulation and testing of methazolamide cyclodextrin eye drop solutions. J. Control. Release 44, 95–99 (1997). doi:10.1016/S0168-3659(96)01506-4

    Article  CAS  Google Scholar 

  20. Higuchi, T., Connors, K.A.: Phase solubility techniques. Adv. Anal. Chem. Instrum. 4, 117–212 (1965)

    CAS  Google Scholar 

  21. Vianna, R.F.L., Bentley, M.V.B., Ribeiro, G., Neto, A.F., de Oliveira, D.C.R., Carvalho, F.S., Collett, J.H.: Formation of cyclodextrin inclusion complexes with corticosteroids: their characterization and stability. Int. J. Pharm. 167, 205–213 (1998). doi:10.1016/S0378-5173(98)00068-4

    Article  CAS  Google Scholar 

  22. Uekama, K., Fujinaga, T., Otagiri, M., Yamasaki, M.: Inclusion complexations of steroid hormones with cyclodextrins in water and in solid phase. Int. J. Pharm. 10, 1–15 (1982). doi:10.1016/0378-5173(82)90057-6

    Article  CAS  Google Scholar 

  23. Zia, V., Rajewski, R.A., Stella, V.J.: Thermodynamics of binding of natural molecules to sulfobutyl ether beta cyclodextrins: the effect of total degree of substitution. Pharm. Res. 17, 936–941 (2000). doi:10.1023/A:1007571019908

    Article  CAS  Google Scholar 

  24. Sadlej-Sosnowska, N.: Influence of the structure of steroid hormones on their association with cyclodextrins: a high-performance liquid chromatography study. J. Incl. Phenom. Macrocycl. Chem. 27, 31–40 (1997). doi:10.1023/A:1007964116987

    Article  CAS  Google Scholar 

  25. Loftsson, T., Matthiasson, K., Masson, M.: The effects of organic salts on the cyclodextrin solubilization of drugs. Int. J. Pharm. 262, 101–107 (2003). doi:10.1016/S0378-5173(03)00334-X

    Article  CAS  Google Scholar 

  26. Loftsson, T., Magnudottir, A., Masson, M., Sigurjonsdottir, J.F.: Self-association and cyclodextrin solubilization of drugs. J. Pharm. Sci. 91, 2307–2316 (2002). doi:10.1002/jps.10226

    Article  CAS  Google Scholar 

  27. Loftsson, T.: Increasing the cyclodextrin complexation of drugs and drug bioavailability through the addition water soluble polymers. Pharmazie 53, 733–740 (1998)

    CAS  Google Scholar 

  28. Duan, M.S., Zhao, N., Ossurardottir, I.B., Thorsteinsson, T., Loftsson, T.: Cyclodextrin solubilization of the antibacterial agents triclosan and triclocarbon: formation of aggregates and higher-order complexes. Int. J. Pharm. 297, 213–222 (2005)

    CAS  Google Scholar 

  29. Loftsson, T., Frioriksdottir, H.: The effect of water-soluble polymer on the aqueous solubility and complexing abilities of β-cyclodextrin. Int. J. Pharm. 163, 115–121 (1998). doi:10.1016/S0378-5173(97)00371-2

    Article  CAS  Google Scholar 

  30. Loftsson, T., Masson, M.: Cyclodextrins in topical drug formulations: theory and practice. Int. J. Pharm. 225, 15–30 (2001). doi:10.1016/S0378-5173(01)00761-X

    Article  CAS  Google Scholar 

  31. Shimpi, S., Chauhan, B., Shimpi, P.: Cyclodextrins: application in different routes of drug administration. Acta Pharm. 55, 139–156 (2005)

    CAS  Google Scholar 

Download references

Acknowledgment

This work was supported financially by a research grant from the Vice Chancellor for Research of Mashhad University of Medical Sciences, Mashhad, Iran.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bizhan Malaekeh-Nikouei.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Malaekeh-Nikouei, B., Sajadi Tabassi, S.A., Ashari, H. et al. Evaluation the effect of cyclodextrin complexation on aqueous solubility of fluorometholone to achieve ophthalmic solution. J Incl Phenom Macrocycl Chem 65, 335–340 (2009). https://doi.org/10.1007/s10847-009-9590-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10847-009-9590-1

Keywords

Navigation